The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intravitreal Injectable Market Research Report 2024
Synopsis
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
The global Intravitreal Injectable market was valued at US$ 14530 million in 2023 and is anticipated to reach US$ 23620 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.
Report Scope
The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by Drug, by Disease, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Drug, by Disease, and by regions.
Market Segmentation
By Company
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Segment by Drug
Anti-VEGF
Steroids
Others
Segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Drug, by Disease, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Drug, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Disease, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Intravitreal Injectable are shot of medicine into the eye. It was first used to administer drugs to treat endophthalmitis and cytomegalovirus retinitis. Recently, it is used to treat age-related macular degeneration and many other retinal diseases as well.
The global Intravitreal Injectable market was valued at US$ 14530 million in 2023 and is anticipated to reach US$ 23620 million by 2030, witnessing a CAGR of 7.1% during the forecast period 2024-2030.
Global Intravitreal Injectable key players include Regeneron Pharmaceuticals (Eylea), Allergan, EyePoint Pharmaceuticals, Genentech, Kanghong Pharmaceutical, etc. Global top five manufacturers hold a share over 70%.
North Amercia is the largest market, with a share over 50%, followed by Europe and Asia-Pacific, both have a share over 40 percent.In terms of drug, Anti-VEGF is the largest segment, with a share over 85%. And in terms of disease, the largest application is Macular Edema, followed by Macular Degeneration, Retinal Vein Occlusion, etc.
This report aims to provide a comprehensive presentation of the global market for Intravitreal Injectable, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Intravitreal Injectable.
Report Scope
The Intravitreal Injectable market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Intravitreal Injectable market comprehensively. Regional market sizes, concerning products by Drug, by Disease, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Intravitreal Injectable manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Drug, by Disease, and by regions.
Market Segmentation
By Company
Regeneron Pharmaceuticals (Eylea)
Allergan
EyePoint Pharmaceuticals
Genentech
Kanghong Pharmaceutical
Segment by Drug
Anti-VEGF
Steroids
Others
Segment by Disease
Macular Degeneration
Macular Edema
Uveitis
Retinal Vein Occlusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Drug, by Disease, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Intravitreal Injectable manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Intravitreal Injectable in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Drug, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Disease, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Intravitreal Injectable Market Overview
1.1 Product Overview and Scope of Intravitreal Injectable
1.2 Intravitreal Injectable Segment by Drug
1.2.1 Global Intravitreal Injectable Market Value Comparison by Drug (2024-2030)
1.2.2 Anti-VEGF
1.2.3 Steroids
1.2.4 Others
1.3 Intravitreal Injectable Segment by Disease
1.3.1 Global Intravitreal Injectable Market Value by Disease: (2024-2030)
1.3.2 Macular Degeneration
1.3.3 Macular Edema
1.3.4 Uveitis
1.3.5 Retinal Vein Occlusion
1.3.6 Others
1.4 Global Intravitreal Injectable Market Size Estimates and Forecasts
1.4.1 Global Intravitreal Injectable Revenue 2019-2030
1.4.2 Global Intravitreal Injectable Sales 2019-2030
1.4.3 Global Intravitreal Injectable Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Intravitreal Injectable Market Competition by Manufacturers
2.1 Global Intravitreal Injectable Sales Market Share by Manufacturers (2019-2024)
2.2 Global Intravitreal Injectable Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Intravitreal Injectable Average Price by Manufacturers (2019-2024)
2.4 Global Intravitreal Injectable Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Intravitreal Injectable, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intravitreal Injectable, Product Type & Application
2.7 Intravitreal Injectable Market Competitive Situation and Trends
2.7.1 Intravitreal Injectable Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intravitreal Injectable Players Market Share by Revenue
2.7.3 Global Intravitreal Injectable Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intravitreal Injectable Retrospective Market Scenario by Region
3.1 Global Intravitreal Injectable Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Intravitreal Injectable Global Intravitreal Injectable Sales by Region: 2019-2030
3.2.1 Global Intravitreal Injectable Sales by Region: 2019-2024
3.2.2 Global Intravitreal Injectable Sales by Region: 2025-2030
3.3 Global Intravitreal Injectable Global Intravitreal Injectable Revenue by Region: 2019-2030
3.3.1 Global Intravitreal Injectable Revenue by Region: 2019-2024
3.3.2 Global Intravitreal Injectable Revenue by Region: 2025-2030
3.4 North America Intravitreal Injectable Market Facts & Figures by Country
3.4.1 North America Intravitreal Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Intravitreal Injectable Sales by Country (2019-2030)
3.4.3 North America Intravitreal Injectable Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intravitreal Injectable Market Facts & Figures by Country
3.5.1 Europe Intravitreal Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Intravitreal Injectable Sales by Country (2019-2030)
3.5.3 Europe Intravitreal Injectable Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intravitreal Injectable Market Facts & Figures by Country
3.6.1 Asia Pacific Intravitreal Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Intravitreal Injectable Sales by Country (2019-2030)
3.6.3 Asia Pacific Intravitreal Injectable Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Intravitreal Injectable Market Facts & Figures by Country
3.7.1 Latin America Intravitreal Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Intravitreal Injectable Sales by Country (2019-2030)
3.7.3 Latin America Intravitreal Injectable Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Intravitreal Injectable Market Facts & Figures by Country
3.8.1 Middle East and Africa Intravitreal Injectable Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Intravitreal Injectable Sales by Country (2019-2030)
3.8.3 Middle East and Africa Intravitreal Injectable Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Drug
4.1 Global Intravitreal Injectable Sales by Drug (2019-2030)
4.1.1 Global Intravitreal Injectable Sales by Drug (2019-2024)
4.1.2 Global Intravitreal Injectable Sales by Drug (2025-2030)
4.1.3 Global Intravitreal Injectable Sales Market Share by Drug (2019-2030)
4.2 Global Intravitreal Injectable Revenue by Drug (2019-2030)
4.2.1 Global Intravitreal Injectable Revenue by Drug (2019-2024)
4.2.2 Global Intravitreal Injectable Revenue by Drug (2025-2030)
4.2.3 Global Intravitreal Injectable Revenue Market Share by Drug (2019-2030)
4.3 Global Intravitreal Injectable Price by Drug (2019-2030)
5 Segment by Disease
5.1 Global Intravitreal Injectable Sales by Disease (2019-2030)
5.1.1 Global Intravitreal Injectable Sales by Disease (2019-2024)
5.1.2 Global Intravitreal Injectable Sales by Disease (2025-2030)
5.1.3 Global Intravitreal Injectable Sales Market Share by Disease (2019-2030)
5.2 Global Intravitreal Injectable Revenue by Disease (2019-2030)
5.2.1 Global Intravitreal Injectable Revenue by Disease (2019-2024)
5.2.2 Global Intravitreal Injectable Revenue by Disease (2025-2030)
5.2.3 Global Intravitreal Injectable Revenue Market Share by Disease (2019-2030)
5.3 Global Intravitreal Injectable Price by Disease (2019-2030)
6 Key Companies Profiled
6.1 Regeneron Pharmaceuticals (Eylea)
6.1.1 Regeneron Pharmaceuticals (Eylea) Corporation Information
6.1.2 Regeneron Pharmaceuticals (Eylea) Description and Business Overview
6.1.3 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Regeneron Pharmaceuticals (Eylea) Intravitreal Injectable Product Portfolio
6.1.5 Regeneron Pharmaceuticals (Eylea) Recent Developments/Updates
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Description and Business Overview
6.2.3 Allergan Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Allergan Intravitreal Injectable Product Portfolio
6.2.5 Allergan Recent Developments/Updates
6.3 EyePoint Pharmaceuticals
6.3.1 EyePoint Pharmaceuticals Corporation Information
6.3.2 EyePoint Pharmaceuticals Description and Business Overview
6.3.3 EyePoint Pharmaceuticals Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.3.4 EyePoint Pharmaceuticals Intravitreal Injectable Product Portfolio
6.3.5 EyePoint Pharmaceuticals Recent Developments/Updates
6.4 Genentech
6.4.1 Genentech Corporation Information
6.4.2 Genentech Description and Business Overview
6.4.3 Genentech Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Genentech Intravitreal Injectable Product Portfolio
6.4.5 Genentech Recent Developments/Updates
6.5 Kanghong Pharmaceutical
6.5.1 Kanghong Pharmaceutical Corporation Information
6.5.2 Kanghong Pharmaceutical Description and Business Overview
6.5.3 Kanghong Pharmaceutical Intravitreal Injectable Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Kanghong Pharmaceutical Intravitreal Injectable Product Portfolio
6.5.5 Kanghong Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intravitreal Injectable Industry Chain Analysis
7.2 Intravitreal Injectable Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intravitreal Injectable Production Mode & Process
7.4 Intravitreal Injectable Sales and Marketing
7.4.1 Intravitreal Injectable Sales Channels
7.4.2 Intravitreal Injectable Distributors
7.5 Intravitreal Injectable Customers
8 Intravitreal Injectable Market Dynamics
8.1 Intravitreal Injectable Industry Trends
8.2 Intravitreal Injectable Market Drivers
8.3 Intravitreal Injectable Market Challenges
8.4 Intravitreal Injectable Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
